DRKS00013251已完成不适用
Vedolizumab Study with Inflammatory Bowel Disease Patients in Germany - VEDOibd I Study
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 1,280
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 80 Years（—）
- 性别
- All
入选标准
- •IBD-patients (UC/CD) aged 18-80 years at enrollment
- •- Written informed consent is given
排除标准
- •Lack of adequate documentation possibilities
- •- Malignant disease in history
- •- Planned surgical intervention
研究者
相似试验
Unknown
不适用
Vedolizumab Study With Inflammatory Bowel Disease Patients in GermanyInflammatory Bowel DiseasesTreatmentNCT03375424Ced Service GmbH2,500
已完成
不适用
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in Real-World PracticeInflammatory Bowel DiseasesCrohns DiseaseColitis, UlcerativeNCT04890262Takeda99
已完成
不适用
Vedolizumab register in patients with inflammatory bowel disease in GermanyK50Crohn disease [regional enteritis]DRKS00008174CED Service GmbH339
招募中
不适用
Biomarkers voor darmkamer bij patiënten met Primair Scleroserende Cholangitis en een inflammatoire darmziekte: de VIP studieNL-OMON26884Academic Medical Center (AMC), Amsterdam40
招募中
不适用
Vedolizumab in PSC and concurrent IBD: Searching for the missing link between the gut and the liver and exploration of biomarkers for development of colorectal carcinoma.NL-OMON55753Academisch Medisch Centrum40